About
Vaccines
Areas of Focus
Categories
Vaccine
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
1
As Collaborator
3
Total Enrollment
2,631
By Phase
PHASE4: 1PHASE3: 3
By Status
COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT04448132Lead Sponsor
Evaluation of Persistence of Immunity in 4-year-old Children Previously Immunised With IPV-Al AJV (Picovax®)
PHASE4Completed
163 participants
Started: Nov 20, 2020 · Completed: May 3, 2021
NCT03671616Collaborator
Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 Months
PHASE3Completed
666 participants
Started: May 15, 2018 · Completed: Oct 3, 2018
NCT03032419Collaborator
Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months
PHASE3Completed
1,002 participants
Started: Feb 6, 2017 · Completed: Mar 12, 2018
NCT03025750Collaborator
Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age
PHASE3Completed
800 participants
Started: Jan 19, 2017 · Completed: Nov 14, 2017
Locations (1)
Headquarters
Copenhagen, Denmark
Map
Loading map...